Academic

Raman spectroscopy for the identification of isocitrate dehydrogenase (IDH) mutated glioblastomas.

Investigated the feasibility of using Raman spectroscopy to differentiate between IDH1 positive (IDH1 + ) and negative (IDH1 - ) tumours through classification modelling. Published Abstract & Poster - Journal of Neuro-Oncology (Volume 19).

Raman spectroscopy for the identification of isocitrate dehydrogenase (IDH) mutation in glioblastomas.

Demonstrated proof of concept that Raman spectroscopy can be used to seperate IDH-1 an IDH-2 gliomas. Abstract and Poster - The International Society for Clinical Spectroscopy 2016, Canada, June 26th - 30th.